Oluwafemi Bakare

Oluwafemi Bakare

orcid
Young professional with interest in research in biochemistry...

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2023 in Molecules
Verified
Journal Article
Open access
PDF file
SOSunday Amos Onikanni
Sunday Amos Onikanni
Bashir LawalBashir Lawal
Bashir Lawal
AFADEWALE FADAKA
ADEWALE FADAKA
OBOluwafemi Bakare
Oluwafemi Bakare
EAEzekiel Adewole
Ezekiel Adewole
Nicole Remaliah Samantha SibuyiNicole Remaliah Samantha Sibuyi
Nicole Remaliah Samantha Sibuyi
The African nutmeg (Monodora myristica) is a medically useful plant. We, herein, aimed to critically examine whether bioactive compounds identified in the extracted oil of Monodora myristica could act as antimicrobial agents. To this end, we employed the Schrödinger platform as the computational tool to screen bioactive compounds identified in the oil of Monodora myristica. Our lead compound displayed the highest potency when compared with levofloxacin based on its binding affinity. The hit molecule was further subjected to an Absorption, Distribution, Metabolism, Excretion (ADME) prediction, and a Molecular Dynamics (MD) simulation was carried out on molecules with PubChem IDs 529885 and 175002 and on three standards (levofloxacin, cephalexin, and novobiocin). The MD analysis results demonstrated that two molecules are highly compact when compared to the native protein; thereby, this suggests that they could affect the protein on a structural and a functional level. The employed computational approach demonstrates that conformational changes occur in DNA gyrase after the binding of inhibitors; thereby, this resulted in structural and functional changes. These findings expand our knowledge on the inhibition of bacterial DNA gyrase and could pave the way for the discovery of new drugs for the treatment of multi-resistant bacterial infections.

30 July 2023 in Molecules
Verified
Journal Article
Open access
PDF file
SOSunday Amos Onikanni
Sunday Amos Onikanni
Bashir LawalBashir Lawal
Bashir Lawal
VMValens Munyembaraga
Valens Munyembaraga
OBOluwafemi Bakare
Oluwafemi Bakare
MTMuhammad Taher
Muhammad Taher
ABAjiboye Basiru
Ajiboye Basiru
Glucokinase plays an important role in regulating the blood glucose level and serves as an essential therapeutic target in type 2 diabetes management. Entada africana is a medicinal plant and highly rich source of bioactive ligands with the potency to develop new target drugs for glucokinase such as diabetes and obesity. Therefore, the study explored a computational approach to predict identified compounds from Entada africana following its intermolecular interactions with the allosteric binding site of the enzymes. We retrieved the three-dimensional (3D) crystal structure of glucokinase (PDB ID: 4L3Q) from the online protein data bank and prepared it using the Maestro 13.5, Schrödinger Suite 2022-3. The compounds identified were subjected to ADME, docking analysis, pharmacophore modeling, and molecular simulation. The results show the binding potential of the identified ligands to the amino acid residues, thereby suggesting an interaction of the amino acids with the ligand at the binding site of the glucokinase activator through conventional chemical bonds such as hydrogen bonds and hydrophobic interactions. The compatibility of the molecules was highly observed when compared with the standard ligand, thereby leading to structural and functional changes. Therefore, the bioactive components from Entada africana could be a good driver of glucokinase, thereby paving the way for the discovery of therapeutic drugs for the treatment of diabetes and its related complications.

7 November 2019 in Asian Journal of Biochemistry, Genetics and Molecular Biology
Verified
Journal Article
Open access
PDF file
AOAfolabi Owoloye
Afolabi Owoloye
OAOlusegun Matthew Akanbi
Olusegun Matthew Akanbi
OBOluwafemi Bakare
Oluwafemi Bakare
Aim: This study aimed to investigate the antiplasmodial activity and effect of stem bark of Terminalia avicennioides made as dietary feed fed to mice infected with Plasmodium berghei, on some serum biochemistry. Methodology: Twenty (20) mice were divided into four groups. Group 1 was not infected with Plasmodium berghei (normal control), Group 2 was infected with P. berghei but not treated (negative control). Group 3 was infected and treated with 5.0 mg/kg of Arthemeter-Lumefantrine (positive control). Groups 4 was infected and fed with treated feed (T. avicennioides). Treatments were carried out for five days. Blood was taken daily from the tail of the mice before treatment for the assessment of parasitaemia. The animals were sacrificed on the fifth day and the whole blood was collected into EDTA bottle. Serum obtained was used to assay for biochemical parameters. Results: Parasitaemia count was significantly lower (p<0.05) in all the treated groups when compared with the negative control group. The high-density lipoprotein was significantly higher (P<0.05) in the normal control (123.14±3.19) when compared with the positive control (99.18±2.76), negative control (85.29±0.85) and the group treated with T avicennioides (86.14±3.21). The serum alanine aminotransferase, alkaline phosphatase and aspartate aminotransferase level in the group treated with T. avicennioides (167.90±4.13, 15.87±1.32 and 17.50±1.95) respectively were significantly reduced (p<0.05) when compared with the negative control (197.25±5.44, 20.01±1.32 and 26.71±0.45) respectively. The mean bilirubin and albumin level in the negative control showed no significant difference when compared with the group fed with T. avicennioides. Conclusion: The study concluded that T. avicennioides have antiplasmodial activity with a mild adverse effect on liver function.

21 April 2025 in Research Square
Verified
Preprint
Open access
PDF file
OBOluwafemi Bakare
Oluwafemi Bakare
SPS. A. Praise
S. A. Praise
SOS. O. Olubode
S. O. Olubode
AKA. T. Kolawole
A. T. Kolawole
MOM. M. Olusanya
M. M. Olusanya
CIC. E. Ikechukwu
C. E. Ikechukwu
Health agencies have reported deaths from the envenomation of snakes, scorpions, and spiders to be a global challenge. Phospholipase A2 (PLA2) and metalloproteinase have been investigated to be major venom enzymes and their inhibition is important for antivenom experimentation. Varespladib (and other drugs such as varespladib-methyl and darapladib) has been mostly used as an antivenin but its cytotoxicity and the drive to source for effective drugs from phytomedicine with little or no side effects and higher potency led to the screening of bioactive compounds of Talinum paniculatum. The bioactive components of the plant with high binding affinities to the protein targets used were identified and subjected to further analysis and studies. After the molecular screening of the compounds of Talinum paniculatum; rutin, kaempferol, quercetin, and Talinumoside1 were established to have high binding affinities to PLA2 and metalloproteinase in comparison to Varespladib (and other compounds such as varespladib-methyl, darapladib, marimastat and ilomastat) used for the study. Quercetin and kaempferol showed better results after the ADMET study and are better drug candidates than the other compounds studied. This research indicates that quercetin and kaempferol may inhibit PLA2, metalloproteinase, and potential antivenins. Further analysis is recommended to substantiate this study.

29 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
OBOluwafemi Bakare
Oluwafemi Bakare
DODaniel Ocha Onwu
Daniel Ocha Onwu
TSToheeb Ayodeji Sodiq
Toheeb Ayodeji Sodiq
OOOnyeka Benjamin Onyeukwu
Onyeka Benjamin Onyeukwu
ALAbdulwarith Olatunji Lawal
Abdulwarith Olatunji Lawal
Olusegun Ayo Ade-adekunleOlusegun Ayo Ade-adekunle
Olusegun Ayo Ade-adekunle
Lassa fever (LF) is a zoonotic viral hemorrhagic disease endemic in West Africa, particularly Nigeria, where recurrent outbreaks continue to pose significant public health challenges. The limited availability of effective antiviral therapies necessitates the identification of repurposable drugs capable of inhibiting viral replication and modulating host molecular targets involved in LF pathogenesis. This study employed an integrated computational drug-repurposing strategy targeting Lassa virus nucleoprotein (NP) and inosine monophosphate dehydrogenase (IMPDH) using network pharmacology, Density Functional Theory (DFT), molecular docking, and molecular dynamics simulations (MDs). Chemical structures of eragidomide, remdesivir, and sofosbuvir were retrieved from the PubChem database, and potential targets were predicted using SwissTargetPrediction. LF-associated genes were obtained from GeneCards, DisGeNET, OMIM, and MalaCards databases, while overlapping targets were identified using Venny 2.1.0. Protein–protein interaction networks were constructed using STRING and visualized in Cytoscape, followed by functional enrichment analysis using the ShinyGO platform. Molecular docking and visualization were performed using BIOVIA Discovery Studio, UCSF Chimera, and PyRx, while Maestro software was used for MM-GBSA binding free-energy calculations and pharmacophore modeling. Docking results demonstrated strong binding interactions with NP and IMPDH, with eragidomide showing the highest affinity toward NP (-11.3 kcal/mol) and favorable interaction with IMPDH (-9.0 kcal/mol). MD simulations conducted over 100 ns indicated stable binding within NP, IMPDH, and EGFR complexes. DFT calculations yielded a total electronic energy of -1973.853045 Eh with an RMS gradient norm of 0.000003 Eh/a₀, confirming optimized and stable molecular geometry of eragidomide. These findings suggest eragidomide as a promising multi-target antiviral candidate against LF replication and host signaling pathways.